Prognosis of Patients with Breast Cancer Following Delayed Diagnosis During the COVID-19 Pandemic: A Real-World Cohort Study
Annals of Surgical Oncology · 2025
DOI: 10.1245/s10434-024-16645-3 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Annals of Surgical Oncology, 2025. Verfasst von Jae Pak Yi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea. Hauptthemen laut MEDLINE: Breast Neoplasms, COVID-19, Delayed Diagnosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has globally impacted healthcare systems, delaying cancer screening, diagnosis, and treatment. South Korea experienced a 3-month lockdown during the peak of the pandemic, leading to postponements in breast cancer diagnosis and treatment. Although the pandemic's severity has decreased, addressing the treatment gap remains a concern. METHODS: This retrospective cohort study included patients diagnosed with breast cancer at five academic hospitals in South Korea during the pre-COVID (May-July 2019) and COVID (May-July 2020) periods. The primary endpoint was recurrence-free survival (RFS), and secondary endpoints included overall survival (OS), stage distribution, and age subgroup analyses. RESULTS: Among 716 patients (374 pre-COVID, 342 COVID), the 3-year RFS was significantly lower in the COVID group (88.3 vs. 89.7%, p = 0.030), while the 3-year OS was similar between groups (96.2 vs. 95.5%, p = 0.439). Age subgroup analysis revealed a significant RFS difference in patients under 65 years of age (p = 0.005) but not in those aged 65 years and older (p = 0.682). Stage distribution did not differ significantly between groups (p = 0.531). CONCLUSIONS: The COVID-19 pandemic adversely affected 3-year RFS, especially among younger patients, despite no significant increase in advanced-stage distribution. Timely cancer screening remains crucial for young patients with fewer infectious disease complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea.
- Department of Medicine, Graduate School, Kyung Hee University, Seoul, Korea.
- Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Department of Surgery, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Department of Surgery, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Korea.
- Department of Surgery, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
Zitieren
APA
Yi, J. P., Yoon, C. I., Lim, S. H., Choi, H., Oh, S. J., Kim, H., Park, D. S., Baek, J. M., Kim, Y. S., Jeon, Y. W., Rhu, J., & Kang, Y. J. (2025). Prognosis of Patients with Breast Cancer Following Delayed Diagnosis During the COVID-19 Pandemic: A Real-World Cohort Study. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-024-16645-3
Vancouver
Yi JP, Yoon CI, Lim SH, Choi H, Oh SJ, Kim H, et al. Prognosis of Patients with Breast Cancer Following Delayed Diagnosis During the COVID-19 Pandemic: A Real-World Cohort Study. Annals of Surgical Oncology. 2025. doi:10.1245/s10434-024-16645-3
BibTeX
@article{Yi2025,
author = {Yi, Jae Pak and Yoon, Chang Ik and Lim, Su Hyun and Choi, Hoon and Oh, Se Jeong and Kim, Hyobin and Park, Dae Sun and Baek, Jong Min and Kim, Yong-Seok and Jeon, Ye Won and Rhu, Jiyoung and Kang, Young-Joon},
title = {Prognosis of Patients with Breast Cancer Following Delayed Diagnosis During the COVID-19 Pandemic: A Real-World Cohort Study},
journal = {Annals of Surgical Oncology},
year = {2025},
doi = {10.1245/s10434-024-16645-3}
}
EUVIMED